Melanoma is a type of skin cancer that develops in melanocytes, the cells that produce melanin and that are responsible for the pigment in your skin. Symptoms include changes in an existing mole, the appearance of a new pigmented or unusual-looking growth, or a dark area under a fingernail or toenail. Treatment depends on the stage of melanoma and may include surgery, immunotherapy, targeted therapy, chemotherapy, or radiation. Sun protection and regular skin checks are crucial for the prevention and early detection of melanoma.
Everyday Health’s team of board-certified physicians and health professionals contribute to the creation and review of content, ensuring that the information is useful, up to date, and accurate.
Jacquelyn Dosal, MD, is a board-certified dermatologist at Skin Associates of South Florida in Coral Gables. She practices general, medical, cosmetic, and surgical dermatology.
Dr. Dosal provides compassionate care to all her patients, listening to their concerns and creating a treatment plan with each patient's priorities and real life in mind.
She is a member of the voluntary faculty at the University of Miami.
Benjamin Izar, MD, PhD, is an assistant professor at Columbia's Vagelos College of Physicians and Surgeons in New York City. He is a physician-scientist within the department of medicine in the division of hematology-oncology, and a member of the department of systems biology. As board-certified medical oncologist, Dr. Izar’s practice is focused on the care of patients with advanced melanoma, including a focus on rare mucosal melanomas. He is also part of the Early-Phase Clinical Trial program at Columbia University Medical Center and the principal investigator on several clinical studies. In his translational research program, he combines clinical care and experimental and computational biology to address fundamental questions on mechanisms of metastasis and resistance to targeted cancer therapies and immune-based therapies.
Danielle Bello, MD, is a general surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. She received her medical degree from Icahn School of Medicine at Mount Sinai, completed her residency in general surgery at Yale University, and her fellowship in surgery at MSKCC.
Yevgeniy (“Eugene”) R. Semenov, MD, is a board-certified dermatologist and assistant professor in dermatology at Harvard Medical School in Boston, with extensive experience in clinical informatics, health economics, and public health research. He received a bachelor’s degree in applied mathematics and statistics, a master’s degree in applied economics, and a medical degree from Johns Hopkins University.
After graduating from medical school, Dr. Semenov pursued an internship in internal medicine at Mercy Medical Center in Baltimore, and residency training in dermatology at Washington University School of Medicine in St. Louis.
Semenov’s clinical expertise includes cutaneous oncology with a focus on melanoma and supportive oncodermatology. His research interests include epidemiology of melanoma and non-melanoma skin cancer with an emphasis on improving outcomes and treatment selection for patients with advanced disease. As part of this clinical and research focus, he provides care to patients experiencing skin side effects from chemotherapy and immunotherapy used for the management of advanced cancers.
Daniel Landau, MD, is a distinguished board-certified hematologist-oncologist with a career that has spanned two eminent institutions: the Orlando Health Cancer Institute and the Medical University of South Carolina. With a specialized interest in genitourinary oncology and hematology, he has been at the forefront of managing both benign and malignant conditions.
Dr. Landau is a pioneering figure in integrating advanced technology into oncology, having served as a director of telemedicine services. Under his leadership, multiple innovative systems have been designed and piloted, all with a singular focus: enhancing the patient experience.
Beyond his clinical and technological endeavors, Landau is deeply committed to medical education. He has dedicated significant time and expertise to nurturing the skills of medical students, residents, and fellows, ensuring that the flame of knowledge and compassion burns bright in the next generation of oncologists.
Albert Chiou, MD, MBA, is a clinical associate professor of dermatology at Stanford University. He received a bachelor's degree from Stanford University and completed an MPhil in Chemistry, by research, from the University of Cambridge, where he was a Gates Cambridge Scholar. He received his medical degree from Harvard Medical School, where he also completed a joint business degree. Dr. Chiou performed his dermatology residency at Stanford University and served as Chief Resident in his final year.
Chiou is also actively involved in clinical trial research investigating new diagnostic paradigms and treatments for a variety of serious or poorly treated chronic dermatologic conditions.
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
